A/P 12.5/15 Pill - yellow round, 9mm
Generic Name: alogliptin/pioglitazone
Pill with imprint A/P 12.5/15 is Yellow, Round and has been identified as Oseni 12.5 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc.
Oseni is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Oseni 12.5 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for A/P 12.5/15
Oseni
- Generic Name
- alogliptin/pioglitazone
- Imprint
- A/P 12.5/15
- Strength
- 12.5 mg / 15 mg
- Color
- Yellow
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America, Inc.
- National Drug Code (NDC)
- 64764-0121 (Discontinued)
- Inactive Ingredients
-
mannitol,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
hypromellose 2910 (6 mPa.s),
titanium dioxide,
polyethylene glycol 8000,
magnesium silicate,
lactose monohydrate,
ferric oxide yellow,
ferric oxide red,
carnauba wax,
polyglyceryl-10 oleate,
butyl alcohol,
alcohol,
shellac
Note: Inactive ingredients may vary.
Related images for "A/P 12.5/15"
More about Oseni (alogliptin / pioglitazone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
